Error message

  • Notice: Undefined variable: program_items in dd_program_feature_get_programs_with_keywords() (line 257 of /var/www/public/sites/all/modules/custom/dd_program_feature/dd_program_feature.module).
  • Warning: Invalid argument supplied for foreach() in dd_program_feature_get_replacements() (line 214 of /var/www/public/sites/all/modules/custom/dd_program_feature/dd_program_feature.module).
  • Notice: Undefined index: table in entity_views_plugin_row_entity_view->init() (line 20 of /var/www/public/sites/all/modules/contrib/entity/views/plugins/


You are here


MOR107 (formerly LP2) is Lanthio Pharma’s lead product in clinical development. MOR107 is a stable and selective agonist of the angiotensin II type 2 (AT2) receptor


Apelins are the endogenous peptide ligands for the APJ receptor. Lanthio Pharma has discovered highly active and stable lanthi-apelins that differentially stimulate APJ-receptor–coupled intracellular pathways.


Natural galanin acts via three different receptor subtypes, GalR1, GalR2 and GalR3. Lanthio Pharma has discovered lanthi-galanins with enhanced subtype receptor specificities.